Eli Lilly’s profit beats expectations thanks to demand for new drugs
Products including diabetes treatment Trulicity and psoriasis drug Taltz selling well
Rejection of arthritis drug hits Eli Lilly and Incyte for $6bn
FDA refuses approval for Baricitinib despite European regulators giving it green light
Weak corporate earnings hit European stocks
In Dublin, Paddy Power shares rise to nearly €136 ahead of merger with Betfair
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices